According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
By Md Mamun Islam RANGPUR, Nov 14, 2024 (BSS) - Rush of patients, manpower shortage and unplanned development in the previous ...
The group was led by Casdin Capital, which surged 16 percent last month, according to an investor. This puts its share class that invests only in public securities up more than 40 percent for the year ...
In Otis' Made to Move Communities™ global competition, students will apply Artificial Intelligence to enable more inclusive ...
To celebrate Science Week and the theme of regeneration, we ask an expert in the field of cell therapy everything you might ...
AstraZeneca in oncology AstraZeneca is leading a revolution in oncology with the ambition to provide ... develop and deliver life-changing medicines to patients. The Company's focus is on some of the ...
Ann Lange was diagnosed with Alzheimer's in 2015, but with the help of clinical trials her disease has not progressed past ...
In a report released on November 7, Jonathan Chang from Leerink Partners reiterated a Buy rating on Revolution Medicines (RVMD – Research ...
Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback